Media headlines about LHC Group (NASDAQ:LHCG) have been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LHC Group earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the health services provider an impact score of 46.7049884137379 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

A number of equities research analysts have recently commented on the company. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Royal Bank Of Canada reissued a “buy” rating and issued a $70.00 target price on shares of LHC Group in a research note on Wednesday, September 6th. Robert W. Baird reissued a “hold” rating and issued a $63.00 target price on shares of LHC Group in a research note on Tuesday, September 12th. Jefferies Group LLC reissued a “buy” rating and issued a $65.00 target price on shares of LHC Group in a research note on Friday, June 9th. Finally, BidaskClub cut LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $66.60.

LHC Group (LHCG) traded up 0.04% during midday trading on Thursday, hitting $70.82. The stock had a trading volume of 144,455 shares. The stock has a market cap of $1.29 billion, a PE ratio of 31.34 and a beta of 0.76. LHC Group has a 52-week low of $32.04 and a 52-week high of $73.85. The company’s 50 day moving average price is $65.80 and its 200-day moving average price is $61.43.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.09. The firm had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The business’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.52 EPS. Analysts forecast that LHC Group will post $2.39 EPS for the current fiscal year.

In related news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the transaction, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 14.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.